Tenet Healthcare (THC) Reports Q3 EPS of 36c, Raises FY14 EBITDA Outlook

Tenet Healthcare (NYSE: THC) reported Q3 EPS of $0.36, may not compare to the analyst estimate of $0.10. Revenue for the quarter came in at $4.18 billion versus the consensus estimate of $4.02 billion.

Tenet Healthcare sees FY2014 EPS of $1.26-$1.78,may not compare to the consensus of $1.42.

The Outlook range for 2014 Adjusted EBITDA is in a range of $1.90 to $1.95 billion, a $25 million mid-point increase as compared to the Company’s prior Outlook of $1.85 to $1.95 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• LeonaBio, Inc. (LONA) Tops Q2 EPS by 32c
• Palo Alto Networks (PANW) PT Raised to $400 at TD Cowen